SpectRx, Inc. Product Pipeline Analysis

SUMMARY

GUIDED THERAPEUTICS, INC. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a GUIDED THERAPEUTICS, INC.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Financial Performance 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Financial Announcements 12
7.1.1 Nov 20, 2007: SpectRx Declares Q3 2007 Results 12
7.1.2 Dec 27, 2006: SpectRx Declares Q3 2006 Results 12
7.1.3 Sep 18, 2006: SpectRx Declares Q2 2006 Results 12
7.1.4 May 22, 2006: SpectRx Declares Q1 2006 Results 13
7.2 Corporate Communications 14
7.2.1 Oct 25, 2007: SpectRx Elects Directors 14
7.2.2 May 14, 2007: SpectRx Appoints New CEO 14
7.2.3 May 11, 2007: SpectRx CEO Retires 15
7.3 Product News 15
7.3.1 Nov 27, 2007: SpectRx, Inc. Signs Agreement To Manufacture And Supply New Non-Invasive Cancer Detection Devices 15
7.3.2 Oct 30, 2007: New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide 15
8 GUIDED THERAPEUTICS, INC. Pipeline Products 16
8.1 GUIDED THERAPEUTICS, INC. Product Pipeline Analysis 16
8.1.1 GUIDED THERAPEUTICS, INC. Pipeline Products By Equipment Type 16
8.1.2 GUIDED THERAPEUTICS, INC. Pipeline Products By Development Stage 17
8.1.3 GUIDED THERAPEUTICS, INC. Pipeline Products By Therapy Area 17
8.1.4 GUIDED THERAPEUTICS, INC. Pipeline Products By Clinical Trials 18
8.1.5 GUIDED THERAPEUTICS, INC. Pipeline Products By News Summary 18
8.2 SpectRx Glucose Monitoring 18
8.2.1 Product Description 18
8.2.2 Product Status 19
8.2.3 Product Patent Details 19
8.3 SpectRx test 19
8.3.1 Product Description 20
8.3.2 Product Status 20
8.3.3 Clinical Trials 20
8.3.4 Product Milestone 21
8.4 Non-invasive breast cancer detection device 21
8.4.1 Product Description 21
8.4.2 Product Status 21
8.4.3 Product Milestone 22
8.4.4 Product Patent Details 22
9 Appendix 23
9.1 Methodology 23
9.1.1 Coverage 23
9.1.2 Secondary Research 24
9.1.3 Primary Research 24
9.1.4 Expert Panel Validation 25
9.2 Contact Us 25
9.3 About Global Markets Direct 25
9.4 Disclaimer 25

1.1 List of Tables
Table 1: GUIDED THERAPEUTICS, INC.,Key Facts 7
Table 2: GUIDED THERAPEUTICS, INC., Key Employees, 10
Table 3: GUIDED THERAPEUTICS, INC. Pipeline Products by Equipment Type 16
Table 4: GUIDED THERAPEUTICS, INC. Pipeline Products By Development Stage 17
Table 5: GUIDED THERAPEUTICS, INC. Pipeline Products By Therapy Area 17
Table 6: GUIDED THERAPEUTICS, INC. Pipeline Products By Clinical Trials 18
Table 7: GUIDED THERAPEUTICS, INC. Pipeline Products By News Summaries 18

1.2 List of Figures
Figure 1: GUIDED THERAPEUTICS, INC. Pipeline Products By Development Stage 17
Figure 2: Global Markets Direct Methodology 23